Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
This article addresses possible mechanisms for development of cardiovascular events (CVE) in type 2 diabetes mellitus (T2DM) patients treated with sulfonylurea derivatives (SU). Several problems are highlighted in this review, including molecular aspects of pancreatic and extrapancreatic action of t...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2013-06-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://dia-endojournals.ru/dia/article/viewFile/3753/1929 |